Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Crivellari

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2009
Identifying optimal adjuvant treatment for individual patients: young age is still an issue?D Crivellari, A Molino
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF)G Toffoli, A Veronesi, M Boiocchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1995
Survival after treatment of advanced renal cell carcinoma (RCC) with high-dose interleukin-2 (rIL-2) or vinblastine (VLB)R Sorio, E Galligioni, D Crivellari, et al.
British Journal of Cancer|April 17, 1999
Anthracycline dose and liver dysfunctionR Cannizzaro, D Crivellari, I Robieux, et al.
Critical Reviews in Oncology/Hematology|January 22, 2005
Incidence of febrile neutropenia and neutropenic infections in elderly patients receiving anthracycline-based chemotherapy for breast cancer without primary prophylaxis with colony-stimulating factorsA Minisini, S Spazzapan, D Crivellari, et al.
Tumori|December 31, 1992
Adjuvant therapy for primary breast cancer in a female patient affected by autoimmune liver disease: does it cure breast cancer and primary biliary cirrhosis?D Crivellari, R Cannizzaro, E Galligioni, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|September 30, 1979
Complement fixing antibody to varicella-zoster virus in cancerous patientsA Peserico, M E Moschen, M Romano, et al.
Clinical Chemistry|January 1, 1993
Biochemical markers for detecting bone metastases in patients with breast cancerL Moro, C Gazzarrini, D Crivellari, et al.
British Journal of Cancer|February 21, 2012
Adjuvant! Online or comprehensive geriatric assessment for women over 70 years with primary breast cancer?S Monfardini, U Basso, P Fiduccia, et al.
American Journal of Clinical Oncology|February 1, 1987
A phase II study of AMSA in head and neck cancerD Crivellari, U Tirelli, S Frustaci, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2009
Identifying optimal adjuvant treatment for individual patients: young age is still an issue?D Crivellari, A Molino
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF)G Toffoli, A Veronesi, M Boiocchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1995
Survival after treatment of advanced renal cell carcinoma (RCC) with high-dose interleukin-2 (rIL-2) or vinblastine (VLB)R Sorio, E Galligioni, D Crivellari, et al.
British Journal of Cancer|April 17, 1999
Anthracycline dose and liver dysfunctionR Cannizzaro, D Crivellari, I Robieux, et al.
Critical Reviews in Oncology/Hematology|January 22, 2005
Incidence of febrile neutropenia and neutropenic infections in elderly patients receiving anthracycline-based chemotherapy for breast cancer without primary prophylaxis with colony-stimulating factorsA Minisini, S Spazzapan, D Crivellari, et al.
Tumori|December 31, 1992
Adjuvant therapy for primary breast cancer in a female patient affected by autoimmune liver disease: does it cure breast cancer and primary biliary cirrhosis?D Crivellari, R Cannizzaro, E Galligioni, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|September 30, 1979
Complement fixing antibody to varicella-zoster virus in cancerous patientsA Peserico, M E Moschen, M Romano, et al.
Clinical Chemistry|January 1, 1993
Biochemical markers for detecting bone metastases in patients with breast cancerL Moro, C Gazzarrini, D Crivellari, et al.
British Journal of Cancer|February 21, 2012
Adjuvant! Online or comprehensive geriatric assessment for women over 70 years with primary breast cancer?S Monfardini, U Basso, P Fiduccia, et al.
American Journal of Clinical Oncology|February 1, 1987
A phase II study of AMSA in head and neck cancerD Crivellari, U Tirelli, S Frustaci, et al.
Pageof 9